Evidence map›Paper›PMID 40303653›Full record

ArticleBulletin of emergency and trauma2025

Association Between Serum Albumin Levels and Clinical Outcomes in Burn Patients: A Single-center Retrospective Analysis.

Maryam Ramezanian, Parissa Bagheri Toolaroud, Cyrus Emiralavi, Mohaya Farzin, Mohammadreza Mobayen, Moein Moghaddam Ahmadi, Mohammad Tolouei, Siamak Rimaz, Mehdi Karimian, Hojat Eftekhari and 2 more

Abstract read
In one paragraph

Article in Bulletin of emergency and trauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maryam RamezanianBurn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Parissa Bagheri ToolaroudBurn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Cyrus EmiralaviRazi Clinical Research Development Unit, Guilan University of Medical Sciences, Rasht, Iran.
Mohaya FarzinDepartment of Physiology, Razi Clinical Research Development Center, Guilan University of Medical Sciences, Rasht, Iran.
Mohammadreza MobayenBurn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Moein Moghaddam AhmadiPoursina Clinical Research Development Unit, Guilan University of Medical Sciences, Rasht. Iran.
Mohammad ToloueiBurn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Siamak RimazBurn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Mehdi KarimianBurn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Hojat EftekhariSkin Research Center, Department of Dermatology, Razi Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Kiana BaghiPoursina Clinical Research Development Unit, Guilan University of Medical Sciences, Rasht. Iran.
Ali ShabbakBurn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Severe burns often result in significant intravascular albumin loss, leading to hypoalbuminemia. This study aimed to evaluate the association between serum albumin levels and clinical outcomes in burn patients. Methods: A retrospective, single-center study was conducted at Velayat Hospital (Rasht, Iran), including burn patients aged ≥16 years, who were admitted between April 2019 and March 2020. Serum albumin levels were recorded on day 1, day 7, and at discharge. The main variables analyzed included albumin levels, length of hospital stay, skin graft rate, need for mechanical ventilation, and mortality. Results: Among the 74 patients included in the study, 14 (18.9%) died, while 60 (81.1%) survived. The mean serum albumin levels on days 1, 7, and at discharge were significantly higher in survivors (3.09±0.22, 3.12±0.23, and 3.18±0.28 g/dL, respectively) than non-survivors (2.22±0.29, 2.74±0.29, and 2.07±0.69 g/dL, respectively) at all time points ( Conclusion: Hypoalbuminemia was associated with poor clinical outcomes in patients with severe burns. Serum albumin levels might serve as a specific marker of burn severity and a predictor of mortality.

Indexed as

AlbuminBurnsMortalitySerum albumin levels

Identifiers

PMID40303653
PMCPMC12036508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.